Deutsch 中文 Contact About us Investors Press Products Career Effective treatment options for many types of cancer Contributing to saving lives The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products. Eckert & Ziegler was founded in 1997 as a holding company. The oldest subsidiary, Eckert & Ziegler BEBIG GmbH, was preceded by the Zentralinstitut für Isotopentechnik, a research institute of the former Academy of Sciences of the GDR. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse. 18-11-2021 Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brasil 12-11-2021 Eckert & Ziegler Announces Clinical Trial Notification for Joint Clinical Trial in Japan Copyright by Eckert & Ziegler. All rights reserved. IMPRINT TERMS OF USE DATA PROTECTION SITEMAP CONTACT

Deutsch Contact About us Investors Press Products Career Share Reports Presentations Press Releases Analyst Reports Annual General Meeting Corporate Governance Financial Calendar IR Contact Home / Investors / Reports / 2005 Financial Reports To view the financial reports, you will need Adobe Acrobat Reader®, which you can download free of charge here. Annual Report 2005 (1.6MByte) Quarterly Report III/2005 (282kByte) Quarterly Report II/2005 (282kByte) Quarterly Report I/2005 (282kByte) 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Copyright by Eckert & Ziegler. All rights reserved. IMPRINT TERMS OF USE DATA PROTECTION SITEMAP CONTACT